Skip to main content
editorial
. 2021 Jul 2;10(4):289–295. doi: 10.1159/000517841

Fig. 1.

Fig. 1

Immune response in cancer. CD8+ T cells are activated and become CTLs upon recognition of cancer antigens presented by MHC class I on dendritic cells. CTLs recognize cancer antigens on the surface of cancer cells through T cell receptors and attack the cancer. TCR, T cell receptor; MHC, major histocompatibility complex; TAA, tumor-associated antigen; DC, dendritic cell. Modified from Abbas et al. [20].